| |

Darryl L. Goss joins Bioreliance
Darryl L. Goss has been appointed Vice
President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly
formed Business Unit.
Click here to read the
press release.
|
|
|
|
|
The bacterial reverse mutation assay evaluates a substance's genotoxicity by comparing its ability to induce reverse mutations at selected loci in several bacterial strains.
Back to Toxicology Home Page
Back to Genetic Toxicology
The purpose of the bacterial reverse mutation assay is to evaluate a chemical's genotoxicity by measuring its ability to induce reverse mutations at selected loci in several bacterial strains.The assay, commonly referred to as the Ames test, was originally
developed by Dr. Bruce Ames and others in the early 1970’s. It is sensitive to a wide range of mutagenic and carcinogenic chemicals (1, 2, 3). This simple, quick and inexpensive genotoxicity assay is one of several genotoxicity assays required for product safety testing of a variety of products including drugs, medical devices, food additives, industrial chemicals and pesticides.
This assay measures genetic damage at the single base level in DNA by using five or more tester strains of bacteria. The Salmonella typhimurium and Escherichia coli strains used in the assay each have a unique mutation that has turned off histidine biosynthesis in Salmonella or tryptophan biosynthesis in E. coli (4, 5). Because of these original mutations, the bacteria require exogenous histidine or tryptophan to survive and will starve to death if grown without these essential nutrients (auxotrophy). The key to the assay is the bacteria can undergo a reverse mutation turning the essential gene back on permitting the cell to grow in the absence of either histidine or tryptophan (prototrophy). Each bacterial strain was created by a specific type of mutation - either a base-pair substitution or frame-shift mutation. Because a reverse, compensating mutation usually must occur by the same mutagenic mechanism, mechanistic toxicology information is also available from Ames assay results based on the pattern of which strain(s) reverted.
The standard Ames assay designs include preliminary toxicology tests or combined toxicity and mutation tests followed by a definitive mutation assay. In both toxicity and mutation tests, tester strains are combined with S9 mix or buffer, test or control article, a trace of histidine or tryptophan and molten agar. The bacteria use the trace histidine or tryptophan to undergo several cell divisions, but will stop growing once they have run out, leaving a characteristic “background lawn” that decreases in density with increasing toxicity. After 48 hours, only those cells that have undergone a reverse mutation turning the essential gene back on have survived, producing mutant colonies. The background lawn density is scored followed by counting the number of revertant colonies. Mutation results are reported as revertants per plate. Figure 1A shows a vehicle control with strain TA 100 and figure 1B shows a positive control plate with TA 100.
Each strain has a characteristic spontaneous background rate and positive control response pattern. Assay evaluation criteria for a positive response look for a dose-related increase of revertant colonies in test article treated cells over concurrent vehicle controls.
The bacterial reverse mutation assay is remarkable in its flexibility and adaptability to unique testing requirements. Many types of test materials have been successfully tested in the Ames assay - often with custom modifications. The following is a list of several custom modifications available to the Ames assay:
- Gasses and volatile liquids
There are a number of approaches for dosing Ames assay plates that involve the metered exposure of compressed gasses or volatile liquids.
- Chemical class-specific modifications
Experience has shown that some chemical classes respond poorly or not at all under standard assay conditions. Specific modifications include use of the “preincubation” method of dosing for some chemicals, use of different species or enzyme induction method for S9 or use of reductive S9 conditions for diazo compounds. Some chemicals with known structure or activity may require the use of a specific strain such as strain TA 102 with cross-linking agents. In these cases, experience is essential in designing and conducting a successful assay.
- Environmental samples
Often biological monitoring of environmental samples provides rapid identification of hazard. Wastewater can be collected using resin exchange columns and extracts testing in the Ames assay. Fugitive gaseous emissions from industrial plants and combustion sources can be sampled and tested.
- Batch monitoring
Specific products or raw materials know to have a specific problem can be monitored by running just the one bacterial strain and/or activation condition that picks up the problem.
- Medical devices and biomaterials
Of special concern for some products is what can be extracted or leached from materials implanted in the body or used to store products. Designs are available to evaluate the mutagenicity of polar and nonpolar extracts of such materials
- Human monitoring
Methods are available for the evaluation of mutagenicity of extracts of human urine. This approach can help monitor humans for exposure to mutagens in occupational and clinical situations.
- Photomutagenicity
Chemicals may be photoactivated to reactive, mutagenic forms. Modifications are available to co-treat the bacterial cells with test article and photo-illumination.
Salmonella / Escherichia coli Reverse Mutation Assay
| ICH/OECD protocol - Plate incorporation method with two trials |
503 |
| ICH/OECD protocol - Preincubation method with two trials |
503001 |
| OECD protocol - Plate incorporation method |
502 |
| ICH/OECD protocol - Plate incorporation method with independent repeat |
502001 |
| ICH/OECD protocol - Plate incorporation method with preincubation independent repeat |
502002 |
| OECD protocol - Preincubation method |
504 |
| ICH/OECD protocol - Preincubation method with independent repeat |
504001 |
|
| Spot Test |
512 |
| Abbreviated Standard Assay |
501 |
| Preincubation Screening Test |
501004 |
| Modified Standard Assay (nontoxic material) |
501027 |
| Modified Standard Assay (unknown toxicity) |
501028 |
| Biocompatibility testing of Medical Devices - Screening test |
502201 |
| Biocompatibility testing of Medical Devices - Full test |
502200 |
| Salmonella / E.coli Plate Incorporation Mutagenicity Assay for Wastewater samples |
506 |
References:
1. McCann, J. and Ames, B.N. (1976). Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals: discussion. Proc. Natl. Acad. Sci. USA 73:950 954.
2. McCann, J., Choi, E., Yamasaki, E. and Ames, B.N. (1975). Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc. Natl. Acad. Sci. USA 72:5135 5139.
3. Maron, D.M. and Ames, B.N. (1983). Revised Methods for the Salmonella Mutagenicity Test. Mutation Research 113:173 215.
4. Ames, B.N., McCann, J. and Yamasaki, E. (1975). Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutation Research 31:347 364.
5. Green, M.H.L., and Muriel, W.J. (1976). Mutagen testing using trp+ reversion in Escherichia coli. Mutation Research 38:3 32.
|
|